The API market is primarily driven by the rising prevalence of chronic diseases, increasing demand for generic drugs, and advancements in drug manufacturing technologies. The growing adoption of biopharmaceuticals, supportive government policies, and an expanding aging population further…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.